One-on-One Support Receive personalized guidance and motivation from our dedicated professionals to keep you on track and achieve your weight loss goals
AU TGA pregnancy category: D US FDA pregnancy category: Not assigned Risk summary: Limited and insufficient data are available on the use of this drug in pregnant women to inform a drug-related risk
It works by increasing dermal papilla cell proliferation, improving blood circulation, and inhibiting DHT, a hormone linked to hair loss, for healthier hair growth
Most healthcare providers start Zepbound at the standard 2.5-mg dose and gradually increase it over time to help minimize side effects, rather than matching it to your previous Wegovy dose
Which GLP-1 agonist is best for weight loss
[46] on semaglutide, we found no increased risk of papillary thyroid carcinoma, the most common type of thyroid cancer, associated with tirzepatide [16,36]